Kafr-Kanna, Israel

Waleed Minzel


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Years Active: 2019-2024

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):
1 patent (EPO):

Title: Waleed Minzel: Innovator in Pharmaceutical Chemistry

Introduction

Waleed Minzel is a notable inventor based in Kafr-Kanna, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrazole pyrimidine derivatives. With a total of three patents to his name, Minzel's inventions focus on addressing critical health issues.

Latest Patents

Minzel's latest patents include the development of pyrazole pyrimidine derivatives that inhibit Casein kinase I (CKI) and Interleukin-1 receptor-associated kinase 1 (IRAKI). These inventions provide methods for their manufacture, compositions comprising them, and their uses in treating malignant diseases and disorders, as well as inflammatory diseases and disorders. This groundbreaking work has the potential to impact the treatment landscape for various health conditions.

Career Highlights

Throughout his career, Waleed Minzel has worked with esteemed organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Biotheryx, Inc. His experience in these companies has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Minzel has collaborated with notable colleagues such as Guy Brachya and Ido Burstain. These partnerships have fostered an environment of innovation and have led to the successful development of his patented technologies.

Conclusion

Waleed Minzel's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work continues to pave the way for advancements in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…